1.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2010; 20 (6): 423
in English
| IMEMR
| ID: emr-98110
Subject(s)
Humans , Male , Middle Aged , Translocation, Genetic , Genes, abl/genetics , Janus Kinase 2/genetics , Proto-Oncogene Proteins c-bcr
2.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2008; 18 (9): 576-577
in English
| IMEMR
| ID: emr-102969
ABSTRACT
The spectrum of plasma cell neoplasm represents indolent conditions like Monoclonal Gammopathy of Undetermined Significance [MGUS] to more aggressive multiple myeloma and plasma cell leukemia. Non-secretory myeloma comprises less than 01% of this spectrum where serum protein electrophoresis and quantitative immunoglobulins remain essentially normal. We are presenting a case report of this rare variant involving the sternum of an adult male
Subject(s)
Humans , Male , Hypergammaglobulinemia , Blood Protein Electrophoresis , Skull/diagnostic imaging , Tomography, X-Ray Computed , Myeloma Proteins , Antineoplastic Agents, Alkylating , Multiple Myeloma/complications
3.
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2008; 18 (3): 176-178
in English
| IMEMR
| ID: emr-100294
ABSTRACT
Imatinib mesylate is a BCR-ABL tyrosine kinase inhibitor used in the management of chronic myeloid leukemia. It is a safe and well-tolerated agent with a few manageable side effects. We are reporting a case of imatinib-related fatal bone marrow aplasia after complete cytogenetic response